Drug Approval | April 09, 2025
Shilpa’s Unit-2 passes second consecutive FDA inspection with no 483s
Raichur site is the group’s largest API facility and part of a wider network of seven sites
Raichur site is the group’s largest API facility and part of a wider network of seven sites
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Increases Siemens’ industrial software total addressable market by $11 billion; aligns with strategic goal to accelerate customer innovation across industries
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Subscribe To Our Newsletter & Stay Updated
